General anesthesia with dexmedetomidine and remifentanil in a neonate during thoracotomy and resection of a congenital cystic adenomatoid malformation

Ellise Cappuccio, Arlyne K. Thung, Joseph D. Tobias

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Based on animal data, concern has been expressed regarding the potential deleterious neurocognitive effects of general anesthesia during infancy and early life. Although there are no definitive data to prove this effect, the neonatal period has been suggested to be the most vulnerable period. While various inhaled and intravenous anesthetic agents have been implicated, dexmedetomidine and the opioids may be devoid of such effects. However, there are limited data regarding the combination of these agents during neonatal surgery and anesthesia. We present the use of these agents in combination with epidural anesthesia for postoperative analgesia in a 1-day-old neonate during thoracotomy and excision of a congental cystic adenomatoid malformation. Previous reports of the use of this unique combination of agents are reviewed and their role in this scenario discussed.

Original languageEnglish (US)
Pages (from-to)215-218
Number of pages4
JournalJournal of Pediatric Pharmacology and Therapeutics
Volume23
Issue number3
DOIs
StatePublished - May 1 2018
Externally publishedYes

Fingerprint

Congenital Cystic Adenomatoid Malformation of Lung
Intravenous Anesthetics
Dexmedetomidine
Anesthesia and Analgesia
Epidural Anesthesia
Thoracotomy
General Anesthesia
Opioid Analgesics
Anesthetics
Anesthesia
remifentanil

Keywords

  • Anesthesia
  • Dexmedetomidine
  • Neurotoxicity
  • Pediatric anesthesia
  • Remifentanil

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pharmacology (medical)

Cite this

@article{bfa8699d7c694b78ae607139aee48979,
title = "General anesthesia with dexmedetomidine and remifentanil in a neonate during thoracotomy and resection of a congenital cystic adenomatoid malformation",
abstract = "Based on animal data, concern has been expressed regarding the potential deleterious neurocognitive effects of general anesthesia during infancy and early life. Although there are no definitive data to prove this effect, the neonatal period has been suggested to be the most vulnerable period. While various inhaled and intravenous anesthetic agents have been implicated, dexmedetomidine and the opioids may be devoid of such effects. However, there are limited data regarding the combination of these agents during neonatal surgery and anesthesia. We present the use of these agents in combination with epidural anesthesia for postoperative analgesia in a 1-day-old neonate during thoracotomy and excision of a congental cystic adenomatoid malformation. Previous reports of the use of this unique combination of agents are reviewed and their role in this scenario discussed.",
keywords = "Anesthesia, Dexmedetomidine, Neurotoxicity, Pediatric anesthesia, Remifentanil",
author = "Ellise Cappuccio and Thung, {Arlyne K.} and Tobias, {Joseph D.}",
year = "2018",
month = "5",
day = "1",
doi = "10.5863/1551-6776-23.3.215",
language = "English (US)",
volume = "23",
pages = "215--218",
journal = "Journal of Pediatric Pharmacology and Therapeutics",
issn = "1551-6776",
publisher = "Pediatric Pharmacology Advocacy Group, Inc.",
number = "3",

}

TY - JOUR

T1 - General anesthesia with dexmedetomidine and remifentanil in a neonate during thoracotomy and resection of a congenital cystic adenomatoid malformation

AU - Cappuccio, Ellise

AU - Thung, Arlyne K.

AU - Tobias, Joseph D.

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Based on animal data, concern has been expressed regarding the potential deleterious neurocognitive effects of general anesthesia during infancy and early life. Although there are no definitive data to prove this effect, the neonatal period has been suggested to be the most vulnerable period. While various inhaled and intravenous anesthetic agents have been implicated, dexmedetomidine and the opioids may be devoid of such effects. However, there are limited data regarding the combination of these agents during neonatal surgery and anesthesia. We present the use of these agents in combination with epidural anesthesia for postoperative analgesia in a 1-day-old neonate during thoracotomy and excision of a congental cystic adenomatoid malformation. Previous reports of the use of this unique combination of agents are reviewed and their role in this scenario discussed.

AB - Based on animal data, concern has been expressed regarding the potential deleterious neurocognitive effects of general anesthesia during infancy and early life. Although there are no definitive data to prove this effect, the neonatal period has been suggested to be the most vulnerable period. While various inhaled and intravenous anesthetic agents have been implicated, dexmedetomidine and the opioids may be devoid of such effects. However, there are limited data regarding the combination of these agents during neonatal surgery and anesthesia. We present the use of these agents in combination with epidural anesthesia for postoperative analgesia in a 1-day-old neonate during thoracotomy and excision of a congental cystic adenomatoid malformation. Previous reports of the use of this unique combination of agents are reviewed and their role in this scenario discussed.

KW - Anesthesia

KW - Dexmedetomidine

KW - Neurotoxicity

KW - Pediatric anesthesia

KW - Remifentanil

UR - http://www.scopus.com/inward/record.url?scp=85051669271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051669271&partnerID=8YFLogxK

U2 - 10.5863/1551-6776-23.3.215

DO - 10.5863/1551-6776-23.3.215

M3 - Article

AN - SCOPUS:85051669271

VL - 23

SP - 215

EP - 218

JO - Journal of Pediatric Pharmacology and Therapeutics

JF - Journal of Pediatric Pharmacology and Therapeutics

SN - 1551-6776

IS - 3

ER -